TransMedics Group, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
TransMedics Group, Inc. (TMDX) reported Revenue from Contract with Customer, Excluding Assessed Tax of $24.30 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2022-11-04
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $24.30M, a 348.97% increase year-over-year.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-06-30 was $20.52M, a 136.77% increase year-over-year.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-03-31 was $15.88M, a 107.94% increase year-over-year.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2021-12-31 was $9.67M, a 17.66% increase year-over-year.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $31.39M, a 10.68% increase from fiscal 2020.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $28.36M, a 9.72% increase from fiscal 2019.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $25.84M, a 76.33% increase from fiscal 2018.
- TransMedics Group, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2018 was $14.66M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2022-09-30 | $24.30M 10-Q · filed 2022-11-04 | $44.82M derived: sum of 2 quarters · filed 2022-11-04 | $60.70M 10-Q · filed 2022-11-04 | $70.37M derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-06-30 | $20.52M 10-Q · filed 2022-08-03 | $36.40M 10-Q · filed 2022-08-03 | $46.07M derived: sum of 3 quarters · filed 2022-08-03 | $51.48M derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-03-31 | $15.88M 10-Q · filed 2022-05-05 | $25.55M derived: sum of 2 quarters · filed 2022-05-05 | $30.96M derived: sum of 3 quarters · filed 2022-11-04 | $39.63M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $15.08M derived: sum of 2 quarters · filed 2022-11-04 | $23.75M derived: sum of 3 quarters · filed 2022-11-04 | $31.39M 10-K · filed 2022-03-01 |
| 2021-09-30 | $5.41M 10-Q · filed 2022-11-04 | $14.08M derived: sum of 2 quarters · filed 2022-11-04 | $21.72M 10-Q · filed 2022-11-04 | $29.93M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $8.67M 10-Q · filed 2022-08-03 | $16.30M 10-Q · filed 2022-08-03 | $24.52M derived: sum of 3 quarters · filed 2022-08-03 | $32.49M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $7.64M 10-Q · filed 2022-05-05 | $15.85M derived: sum of 2 quarters · filed 2022-05-05 | $23.83M derived: sum of 3 quarters · filed 2022-05-05 | $27.75M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $8.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $16.19M derived: sum of 2 quarters · filed 2022-03-01 | $20.11M derived: sum of 3 quarters · filed 2022-03-01 | $28.36M 10-K · filed 2022-03-01 |
| 2020-09-30 | $7.97M 10-Q · filed 2021-11-09 | $11.90M derived: sum of 2 quarters · filed 2021-11-09 | $20.14M 10-Q · filed 2021-11-09 | $26.60M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.92M 10-Q · filed 2021-08-06 | $12.17M 10-Q · filed 2021-08-06 | $18.63M derived: sum of 3 quarters · filed 2021-08-06 | $26.50M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $8.24M 10-Q · filed 2021-05-07 | $14.71M derived: sum of 2 quarters · filed 2021-05-07 | $22.58M derived: sum of 3 quarters · filed 2021-05-07 | $28.80M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $6.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $14.34M derived: sum of 2 quarters · filed 2021-03-11 | $20.55M derived: sum of 3 quarters · filed 2021-03-11 | $25.84M 10-K · filed 2021-03-11 |
| 2019-09-28 | $7.88M 10-Q · filed 2020-11-06 | $14.09M derived: sum of 2 quarters · filed 2020-11-06 | $19.38M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $6.21M 10-Q · filed 2020-08-07 | $11.51M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $5.29M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $14.66M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $4.75M 10-Q · filed 2019-11-08 | $8.02M derived: sum of 2 quarters · filed 2019-11-08 | $10.78M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $3.26M 10-Q · filed 2019-08-08 | $6.02M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $2.76M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |